Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Getting the right drug into the right patient

Nature Biotechnology volume 16, pages 9–12 (1998)Cite this article

Pharmacogenomics will help explain why drugs work better in some patients than in others. It also presents numerous commercial opportunities for both startups and established biotechnology companies.

Pharmaceutical medicine today is geared around taking statistical information about the general population and applying it to the individual: Physicians make empirical decisions about types of treatment and drug dosage during the initial consultation with a patient; only after the individual returns following the first course of treatment is the prescription "personalized," and only then by varying the dosage.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Pharmaceutical Researchers and Manufacturers of America.

  2. Poirer, J. et al. 1995. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc. Natl. Acad. Sci. USA 92: 12260–12264.

    Article  Google Scholar 

  3. Farlow, M.R. et al. 1996. Apolipoprotein E genotype and gender influence response to tacrine therapy. Ann. N.Y. Acad. Sci. 802: 101–110.

    Article  Google Scholar 

  4. Richard, F. et al. 1997. APOE genotyping and response to drug treatment in Alzheimer's disease. Lancet 349: 539.

    Article  Google Scholar 

  5. Department of Health and Human Services. 1997. Guidance for Industry: Drug Metabolism/Drug Interaction Studies in the Drug Development Process: Studies in Vitro. FDA, Rockville, MD.

Download references

Author information

Authors and Affiliations

  1. Andrew Marshall

Authors
  1. Andrew Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marshall, A. Getting the right drug into the right patient. Nat Biotechnol 16 (Suppl 2), 9–12 (1998). https://doi.org/10.1038/5141

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/5141

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing